Although this study excluded cases in which TTF-1 immunostaining had not been performed in patients diagnosed with adenocarcinoma in HE staining, the response of these patients to platinum-doublet chemotherapy was very similar to that of patients who were TTF-1-positive (Supplementary Figure S1). This evidence concerns the gene TTF1 and adenocarcinoma.